Artigo Revisado por pares

Applying patent survival analysis in the academic context

2015; Oxford University Press; Volume: 24; Issue: 2 Linguagem: Inglês

10.1093/reseval/rvu037

ISSN

1471-5449

Autores

Danielle Lewensohn, Charlotta Dahlborg, Jan Kowalski, Per Lundin,

Tópico(s)

Firm Innovation and Growth

Resumo

Journal Article Applying patent survival analysis in the academic context Get access Danielle Lewensohn, Danielle Lewensohn * 1 Unit for Bioentrepreneurship, Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Tomtebodavägen 18A, 171 77 Stockholm, Sweden, 2 Unit of Paediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, K 54, 141 86 Huddinge, Sweden, 3 JK Biostatistics, Vasavägen 6, 554 46 Jönköping, Sweden, 4 Department of Molecular Medicine and Surgery (MMK), Karolinska Institutet, Karolinska University Hospital Solna (L1:00), 171 76 Stockholm, Sweden and 5 Thomson Reuters IP & Science, Kungsgatan 15, 111 35 Stockholm, Sweden *Corresponding author. Email: danielle.lewensohn@ki.se Search for other works by this author on: Oxford Academic Google Scholar Charlotta Dahlborg, Charlotta Dahlborg 1 Unit for Bioentrepreneurship, Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Tomtebodavägen 18A, 171 77 Stockholm, Sweden, 2 Unit of Paediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, K 54, 141 86 Huddinge, Sweden, 3 JK Biostatistics, Vasavägen 6, 554 46 Jönköping, Sweden, 4 Department of Molecular Medicine and Surgery (MMK), Karolinska Institutet, Karolinska University Hospital Solna (L1:00), 171 76 Stockholm, Sweden and 5 Thomson Reuters IP & Science, Kungsgatan 15, 111 35 Stockholm, Sweden Search for other works by this author on: Oxford Academic Google Scholar Jan Kowalski, Jan Kowalski 1 Unit for Bioentrepreneurship, Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Tomtebodavägen 18A, 171 77 Stockholm, Sweden, 2 Unit of Paediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, K 54, 141 86 Huddinge, Sweden, 3 JK Biostatistics, Vasavägen 6, 554 46 Jönköping, Sweden, 4 Department of Molecular Medicine and Surgery (MMK), Karolinska Institutet, Karolinska University Hospital Solna (L1:00), 171 76 Stockholm, Sweden and 5 Thomson Reuters IP & Science, Kungsgatan 15, 111 35 Stockholm, Sweden Search for other works by this author on: Oxford Academic Google Scholar Per Lundin Per Lundin 1 Unit for Bioentrepreneurship, Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet, Tomtebodavägen 18A, 171 77 Stockholm, Sweden, 2 Unit of Paediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Karolinska University Hospital, Alfred Nobels Allé 8, K 54, 141 86 Huddinge, Sweden, 3 JK Biostatistics, Vasavägen 6, 554 46 Jönköping, Sweden, 4 Department of Molecular Medicine and Surgery (MMK), Karolinska Institutet, Karolinska University Hospital Solna (L1:00), 171 76 Stockholm, Sweden and 5 Thomson Reuters IP & Science, Kungsgatan 15, 111 35 Stockholm, Sweden Search for other works by this author on: Oxford Academic Google Scholar Research Evaluation, Volume 24, Issue 2, April 2015, Pages 197–212, https://doi.org/10.1093/reseval/rvu037 Published: 19 February 2015

Referência(s)
Altmetric
PlumX